[Adipokines, body composition and bone mineral density in underweight children]. 2015

Jadwiga Ambroszkiewicz, and Witold Klemarczyk, and Grazna Rowicka, and Magdalena Chełchowska, and Mariusz Ołtarzewski, and Joanna Gajewska
Institute of Mother and Child in Warsaw, Poland: Screening Department.

One of the important factors affecting bone health is body weight. Underweight children are predisposed to disturbances in bone metabolism, which may result in osteopenia and osteoporosis in later life. OBJECTIVE The aim of the study was to assess the relationship between adipokines, bone metabolism, and anthropometric parameters in underweight prepubertal children. METHODS The study included 60 children aged 5-10 years. Among them, there were: 30 underweight children (BMI z-score ≤-1) and 30 normal-weight children (BMI z-score <-1 + 1 >). Body composition (fat mass, lean body mass, bone mass) and bone mineral density examination were performed by densitometry. Serum concentrations of bone metabolism markers and adipokines were determined by immunoenzymatic methods. RESULTS In underweight children we observed significantly lower fat mass (p<0.0001), lean mass (p<0.001), bone mineral content (p<0.01) and bone mineral density both the total body (p<0.01) as well as lumbar spine L2-L4 (p<0.05) compared with normal-weight children. In the group of underweight children, serum concentration of bone resorption marker (CTX) was significantly higher than in normal-weight children (2.006±0.649 vs. 1.624±0.492 ng/ml, p<0.05), with no differences in the concentrations of osteocalcin and sclerostin between studied groups. The ratio of adipokines (leptin/adiponectin) was approximately 2-fold lower in underweight than in normal-weight subjects. In underweight children we observed positive correlations between concentrations of sclerostin and bone turnover markers (OC, CTX) and between adiponectin and CTX. However, there was no correlation between fat mass and leptin concentration in this group of children. CONCLUSIONS Low body weight in prepubertal period is related with an alteration in the adipokines profile and bone metabolism markers, resulting in a decrease in bone mineral density.

UI MeSH Term Description Entries
D008297 Male Males
D001823 Body Composition The relative amounts of various components in the body, such as percentage of body fat. Body Compositions,Composition, Body,Compositions, Body
D001842 Bone and Bones A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principal cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX. Bone Tissue,Bone and Bone,Bone,Bones,Bones and Bone,Bones and Bone Tissue,Bony Apophyses,Bony Apophysis,Condyle,Apophyses, Bony,Apophysis, Bony,Bone Tissues,Condyles,Tissue, Bone,Tissues, Bone
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000886 Anthropometry The technique that deals with the measurement of the size, weight, and proportions of the human or other primate body.
D013851 Thinness A state of insufficient flesh on the body usually defined as having a body weight less than skeletal and physical standards, such as BODY MASS INDEX, and dependent on age, sex, and genetic background. Leanness,Underweight
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune

Related Publications

Jadwiga Ambroszkiewicz, and Witold Klemarczyk, and Grazna Rowicka, and Magdalena Chełchowska, and Mariusz Ołtarzewski, and Joanna Gajewska
January 2000, Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA,
Jadwiga Ambroszkiewicz, and Witold Klemarczyk, and Grazna Rowicka, and Magdalena Chełchowska, and Mariusz Ołtarzewski, and Joanna Gajewska
July 2009, Journal of endocrinological investigation,
Jadwiga Ambroszkiewicz, and Witold Klemarczyk, and Grazna Rowicka, and Magdalena Chełchowska, and Mariusz Ołtarzewski, and Joanna Gajewska
April 2019, Bone,
Jadwiga Ambroszkiewicz, and Witold Klemarczyk, and Grazna Rowicka, and Magdalena Chełchowska, and Mariusz Ołtarzewski, and Joanna Gajewska
June 2018, Clinical endocrinology,
Jadwiga Ambroszkiewicz, and Witold Klemarczyk, and Grazna Rowicka, and Magdalena Chełchowska, and Mariusz Ołtarzewski, and Joanna Gajewska
June 2015, Pediatric blood & cancer,
Jadwiga Ambroszkiewicz, and Witold Klemarczyk, and Grazna Rowicka, and Magdalena Chełchowska, and Mariusz Ołtarzewski, and Joanna Gajewska
May 2022, BMC pediatrics,
Jadwiga Ambroszkiewicz, and Witold Klemarczyk, and Grazna Rowicka, and Magdalena Chełchowska, and Mariusz Ołtarzewski, and Joanna Gajewska
March 2019, Nutrition (Burbank, Los Angeles County, Calif.),
Jadwiga Ambroszkiewicz, and Witold Klemarczyk, and Grazna Rowicka, and Magdalena Chełchowska, and Mariusz Ołtarzewski, and Joanna Gajewska
February 2009, Pediatric radiology,
Jadwiga Ambroszkiewicz, and Witold Klemarczyk, and Grazna Rowicka, and Magdalena Chełchowska, and Mariusz Ołtarzewski, and Joanna Gajewska
November 2009, The Journal of clinical endocrinology and metabolism,
Jadwiga Ambroszkiewicz, and Witold Klemarczyk, and Grazna Rowicka, and Magdalena Chełchowska, and Mariusz Ołtarzewski, and Joanna Gajewska
July 1995, The Journal of clinical endocrinology and metabolism,
Copied contents to your clipboard!